Variant report

Variant	rs1729290
Chromosome Location	chr11:47996131-47996132
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr11:47993972..47999221-chr11:48000961..48004940,8	MCF-7	breast:
2	chr11:47994952..47996507-chr11:48001378..48004239,2	K562	blood:
3	chr11:47994688..47998306-chr11:48000477..48003009,4	MCF-7	breast:

Variant related genes	Relation type
ENSG00000149177	Chromatin interaction

Extended variants
information (count: 13 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1052397	chr11:47675470-48594256	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	97 gene(s)	inside rSNPs	diseases
2	nsv530620	chr11:47765455-48664555	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
3	nsv1036992	chr11:47794621-48666024	Strong transcription Flanking Active TSS Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
4	nsv897326	chr11:47891334-48035474	Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
5	nsv1036451	chr11:47902321-48616646	Weak transcription Enhancers ZNF genes & repeats Strong transcription Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
6	nsv541037	chr11:47902321-48616646	Enhancers Strong transcription Genic enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
7	nsv1047490	chr11:47916708-48388686	Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
8	nsv1044266	chr11:47929586-48276132	Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
9	nsv541038	chr11:47929586-48276132	Weak transcription Enhancers ZNF genes & repeats Strong transcription Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
10	nsv1053145	chr11:47967902-48086950	Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases
11	nsv870381	chr11:47989434-48142648	Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Active TSS Strong transcription Genic enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA	5 gene(s)	inside rSNPs	diseases
12	esv3396029	chr11:47993857-48241494	Weak transcription Strong transcription Transcr. at gene 5' and 3' Enhancers Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	6 gene(s)	inside rSNPs	diseases
13	nsv317	chr11:47995903-48007266	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region	1 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:73 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:47993400-48001400	Weak transcription	Right Atrium	heart
2	chr11:47994400-47997400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr11:47994600-47996800	Enhancers	Muscle Satellite Cultured Cells	--
4	chr11:47994600-47996800	Enhancers	HSMM	muscle
5	chr11:47994800-47996200	Enhancers	Osteobl	bone
6	chr11:47994800-47996400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
7	chr11:47994800-47996600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr11:47994800-47996600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
9	chr11:47994800-47996600	Enhancers	NHLF	lung
10	chr11:47994800-47996800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr11:47994800-47997000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr11:47994800-47997000	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr11:47994800-47997200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
14	chr11:47994800-47997200	Enhancers	Primary B cells from cord blood	blood
15	chr11:47994800-47997200	Enhancers	Cortex derived primary cultured neurospheres	brain
16	chr11:47994800-47997400	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr11:47995000-47996200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr11:47995000-47996600	Enhancers	H1 Cell Line	embryonic stem cell
19	chr11:47995000-47996600	Enhancers	HUES64 Cell Line	embryonic stem cell
20	chr11:47995000-47996800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr11:47995000-47996800	Enhancers	NHDF-Ad	bronchial
22	chr11:47995000-47997200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr11:47995000-47997400	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr11:47995000-47997800	Enhancers	Placenta	Placenta
25	chr11:47995200-47996200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
26	chr11:47995200-47996200	Enhancers	Brain Substantia Nigra	brain
27	chr11:47995200-47996600	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr11:47995200-47996600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
29	chr11:47995200-47996600	Enhancers	HSMMtube	muscle
30	chr11:47995200-47996800	Enhancers	HUES6 Cell Line	embryonic stem cell
31	chr11:47995200-47996800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
32	chr11:47995200-47997000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
33	chr11:47995200-47997400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
34	chr11:47995200-47997400	Enhancers	Primary B cells from peripheral blood	blood
35	chr11:47995200-47997400	Enhancers	Monocytes-CD14+_RO01746	blood
36	chr11:47995400-47996200	Enhancers	NHEK	skin
37	chr11:47995400-47996400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
38	chr11:47995400-47996400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
39	chr11:47995400-47996400	Enhancers	Brain Hippocampus Middle	brain
40	chr11:47995400-47996400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr11:47995400-47996400	Enhancers	Fetal Lung	lung
42	chr11:47995400-47996400	Enhancers	Stomach Mucosa	stomach
43	chr11:47995400-47996600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
44	chr11:47995400-47996600	Enhancers	H9 Cell Line	embryonic stem cell
45	chr11:47995400-47996600	Enhancers	iPS-15b Cell Line	embryonic stem cell
46	chr11:47995400-47996600	Enhancers	Primary hematopoietic stem cells short term culture	blood
47	chr11:47995400-47996600	Enhancers	Adipose Nuclei	Adipose
48	chr11:47995400-47996600	Enhancers	Duodenum Smooth Muscle	Duodenum
49	chr11:47995400-47996600	Enhancers	Hela-S3	cervix
50	chr11:47995400-47997000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links